Kenneth Hoberman - 20 Jul 2022 Form 4 Insider Report for TG THERAPEUTICS, INC. (TGTX)

Role
Director
Signature
/s/ Kenneth Hoberman
Issuer symbol
TGTX
Transactions as of
20 Jul 2022
Transactions value $
$0
Form type
4
Filing time
22 Jul 2022, 16:31:41 UTC
Previous filing
16 May 2022
Next filing
20 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGTX Common Stock Award $0 +43.7K +24.44% $0.00 223K 20 Jul 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reflects a grant of restricted shares that will vest on June 15, 2023.
F2 Includes shares of restricted Common Stock, which vest over various time periods.